WHITEHOUSE STATION, N.J., Jan. 14 (UPI) -- Merck is voluntarily recalling all lots of Liptruzet, or ezetimibe and atorvastatin, in the United States due to packaging defects, officials say. The drug company is recalling from wholesalers ...
Tags: Liptruzet, wholesaler, USA, FDA
Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock. Merck said the foil pouches holding Liptruzet pills could allow air and ...
Tags: recall, Liptruzet, Merck, packaging defects
US-based pharmaceutical company Merck & Co has recalled Liptruzet products from wholesalers in the domestic market due to a defect in the product's packaging. The defective outer laminated foil pouches are liable to allow air and moisture ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is voluntarily recalling all lots of Liptruzet (ezetimibe and atorvastatin) 10/10 mg, 10/20 mg, 10/40 mg and 10/80 mg tablets in the United States, including Puerto Rico, ...
Tags: Health, Medicine, Medicine Packaging
Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock. Merck said the foil pouches holding Liptruzet pills could allow air and ...
Tags: Drug, Health, Medicine, Drug Packaging, Packaging
Think a pill that packs two cholesterol-lowering drugs in one potent package is a good idea? The Food and Drug Administration thinks so. It recently approved the combination of the popular statin drug Lipitor (atorvastatin) with another ...
Merck, referred to as MSD outside the US and Canada, has obtained FDA approval for Liptruzet tablets as an adjunctive therapy to diet for the treatment of elevated low-density lipoprotein (LDL) cholesterol in primary or mixed hyperlipidemia ...
Tags: Merck, Liptruzet Tablets